Inhibition of platelet aggregation by dialysable fibrinogen degradation products (FDP).
D000227:Adenine Nucleotides / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects*; D001798:Blood Proteins / Q000032:analysis; D002845:Chromatography; D004837:Epinephrine / Q000494:pharmacology; D005340:Fibrinogen / Q000378:metabolism*; D005342:Fibrinolysis; D005343:Fibrinolytic Agents; D006801:Humans; D008970:Molecular Weight; D009638:Norepinephrine / Q000494:pharmacology; D010973:Platelet Adhesiveness / Q000187:drug effects; D013053:Spectrophotometry; D013917:Thrombin / Q000494:pharmacology
D000227:Adenine Nucleotides; D001798:Blood Proteins; D005343:Fibrinolytic Agents; D005340:Fibrinogen; D013917:Thrombin; D009638:Norepinephrine; D004837:Epinephrine